 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Novo Holdings A/S
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2015-11-17 Sale | 2015-11-19 5:55 pm | Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner | 225,000 | $9.7915 | $2,203,079 | 2,471,405 (Direct) | View |
| 2016-03-02 Sale | 2016-03-04 6:34 pm | Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner | 190,000 | $6.8005 | $1,292,086 | 2,281,405 (Direct) | View |
| 2016-03-29 Purchase | 2016-03-30 1:07 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner | 666,666 | $15 | $9,999,990 | 3,154,046 (Direct) | View |
| 2016-05-12 Purchase | 2016-05-16 5:01 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner | 70,000 | $10 | $700,000 | 3,224,046 (Direct) | View |
| 2016-05-24 Sale | 2016-05-25 5:17 pm | Ophthotech Corp. | OPHT | Novo A/S 10% Owner | 1,300,000 | $49 | $63,700,000 | 3,610,489 (Direct) | View |
| 2016-06-01 Purchase | 2016-06-02 4:17 pm | REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner | 750,000 | $11 | $8,250,000 | 750,000 (Direct) | View |
| 2016-06-06 Sale | 2016-06-07 5:08 pm | Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner | 187,500 | $10.37 | $1,943,906 | 2,093,905 (Direct) | View |
| 2016-06-28 Sale | 2016-06-30 6:01 pm | Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner | 66,814 | $13.04 | $870,941 | 2,027,091 (Direct) | View |
| 2016-07-05 Sale | 2016-07-07 6:46 pm | Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner | 92,119 | $12.2 | $1,124,131 | 1,934,972 (Direct) | View |
| 2016-07-11 Sale | 2016-07-13 6:26 pm | Tobira Therapeutics Inc. | TBRA | Novo A/S 10% Owner | 59,067 | $12.02 | $710,118 | 1,875,905 (Direct) | View |
| 2016-09-09 Purchase | 2016-09-13 11:48 am | CoLucid Pharmaceuticals Inc. | CLCD | Novo A/S 10% Owner | 100,000 | $20 | $2,000,000 | 3,156,563 (Direct) | View |
| 2016-10-25 Purchase | 2016-10-26 4:46 pm | iRhythm Technologies Inc. | IRTC | Novo A/S 10% Owner | 100,000 | $17 | $1,700,000 | 2,124,448 (Direct) | View |
| 2016-10-31 Purchase | 2016-11-02 4:54 pm | Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner | 246,154 | $13 | $3,200,002 | 2,031,562 (Direct) | View |
| 2016-12-14 Sale | 2016-12-16 6:29 pm | Ophthotech Corp. | OPHT | Novo A/S 10% Owner | 3,610,487 | $4.8742 | $17,598,385 | 0 (Direct) | View |
| 2017-01-31 Purchase | 2017-02-01 4:22 pm | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 50,000 | $15 | $750,000 | 3,033,504 (Direct) | View |
| 2017-05-10 Sale | 2017-05-11 6:00 pm | Apollo Endosurgery Inc. | APEN | Novo A/S 10% Owner | 105,000 | $5.6257 | $590,703 | 1,351,972 (Direct) | View |
| 2017-06-05 Sale | 2017-06-07 7:01 pm | REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner | 89,497 | $28.24 | $2,527,394 | 876,297 (Direct) | View |
| 2017-06-08 Sale | 2017-06-12 6:12 pm | REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner | 222,503 | $25.71 | $5,719,779 | 653,794 (Direct) | View |
| 2017-06-13 Sale | 2017-06-14 4:39 pm | REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner | 61,000 | $25.11 | $1,531,926 | 592,794 (Direct) | View |
| 2017-06-23 Purchase | 2017-06-27 4:52 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner | 20,000 | $10.95 | $219,000 | 3,244,046 (Direct) | View |
| 2017-07-24 Sale | 2017-07-26 7:22 pm | Apollo Endosurgery Inc. | APEN | Novo Holdings A/S 10% Owner | 50,130 | $6.8974 | $345,766 | 1,301,842 (Direct) | View |
| 2017-08-01 Sale | 2017-08-03 5:21 pm | ANAPTYSBIO INC | ANAB | Novo Holdings A/S 10% Owner | 70,706 | $23.31 | $1,647,947 | 2,962,798 (Direct) | View |
| 2017-08-04 Sale | 2017-08-08 6:08 pm | ANAPTYSBIO INC | ANAB | Novo Holdings A/S 10% Owner | 491,294 | $21.12 | $10,377,406 | 2,471,504 (Direct) | View |
| 2017-08-14 Sale | 2017-08-16 4:56 pm | ANAPTYSBIO INC | ANAB | Novo Holdings A/S 10% Owner | 178,600 | $21.16 | $3,778,481 | 2,292,904 (Direct) | View |
| 2017-08-21 Sale | 2017-08-21 5:11 pm | ANAPTYSBIO INC | ANAB | Novo Holdings A/S 10% Owner | 356,300 | $21.1 | $7,518,251 | 1,936,604 (Direct) | View |
| 2017-08-18 Sale | 2017-08-22 7:25 pm | HTG MOLECULAR DIAGNOSTICS INC | HTGM | Novo Holdings A/S 10% Owner | 80,586 | $2.0722 | $166,988 | 1,199,599 (Direct) | View |
| 2017-08-23 Sale | 2017-08-25 7:17 pm | HTG MOLECULAR DIAGNOSTICS INC | HTGM | Novo Holdings A/S 10% Owner | 1,149,813 | $1.8142 | $2,085,985 | 0 (Direct Indirect) | View |
| 2017-09-13 Sale | 2017-09-15 7:18 pm | KalVista Pharmaceuticals Inc. | KALV | Novo Holdings A/S 10% Owner | 176,647 | $7.212 | $1,273,980 | 2,725,280 (Direct) | View |
| 2017-09-13 Sale(A) | 2017-09-18 7:04 pm | KalVista Pharmaceuticals Inc. | KALV | Novo Holdings A/S 10% Owner | 176,644 | $7.212 | $1,273,956 | 2,725,283 (Direct) | View |
| 2017-10-10 Sale | 2017-10-12 5:21 pm | KalVista Pharmaceuticals Inc. | KALV | Novo Holdings A/S 10% Owner | 2,725,283 | $9.6398 | $26,271,182 | 0 (Direct) | View |
| 2018-03-12 Purchase | 2018-03-13 5:12 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner | 1,176,470 | $8.5 | $9,999,995 | 4,420,516 (Direct) | View |
| 2018-09-28 Purchase | 2018-10-01 4:36 pm | Entasis Therapeutics Holdings Inc. | ETTX | Novo Holdings A/S 10% Owner | 1,089,835 | $15 | $16,347,525 | 2,181,843 (Direct) | View |
| 2019-05-13 Purchase | 2019-05-14 4:31 pm | Milestone Pharmaceuticals Inc. | MIST | Novo Holdings A/S 10% Owner | 333,333 | $15 | $4,999,995 | 2,674,470 (Direct) | View |
| 2019-06-28 Purchase | 2019-07-01 4:31 pm | Morphic Holding Inc. | MORF | Novo Holdings A/S 10% Owner | 666,667 | $15 | $10,000,005 | 2,645,446 (Direct) | View |
| 2019-07-22 Purchase | 2019-07-23 4:32 pm | Mirum Pharmaceuticals Inc. | MIRM | Novo Holdings A/S 10% Owner | 575,000 | $15 | $8,625,000 | 2,445,147 (Direct) | View |
| 2019-07-23 Sale | 2019-07-25 7:21 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner | 1,492,956 | $4.071 | $6,077,845 | 2,927,560 (Direct) | View |
| 2019-11-12 Purchase | 2019-11-14 2:16 pm | Galera Therapeutics Inc. | GRTX | Novo Holdings A/S 10% Owner | 500,000 | $12 | $6,000,000 | 3,409,021 (Direct) | View |
| 2019-11-25 Sale | 2019-11-27 2:39 pm | Milestone Pharmaceuticals Inc. | MIST | Novo Holdings A/S 10% Owner | 240,000 | $16 | $3,840,000 | 2,434,470 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-03-29 Conversion | 2016-03-30 1:07 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner | 2,130,492 | $0 | 3,154,046 (Direct) | View |
| 2016-03-29 Conversion | 2016-03-30 1:07 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner | 356,888 | $0 | 3,154,046 (Direct) | View |
| 2016-03-29 Conversion | 2016-03-30 1:07 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner | 2,130,492 | $0 | 3,154,046 (Direct) | View |
| 2016-03-29 Conversion | 2016-03-30 1:07 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | Novo A/S 10% Owner | 356,888 | $0 | 3,154,046 (Direct) | View |
| 2016-06-01 Conversion | 2016-08-05 11:41 am | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner | 215,794 | $0 | 2,401,969 (Direct) | View |
| 2016-06-01 Conversion | 2016-08-05 11:41 am | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Novo A/S 10% Owner | 215,794 | $0 | 2,401,969 (Direct) | View |
| 2016-10-25 Conversion | 2016-10-26 4:46 pm | N/A N/A | iRhythm Technologies Inc. | IRTC | Novo A/S 10% Owner | 2,007,449 | $0 | 2,124,448 (Direct) | View |
| 2016-10-25 Conversion | 2016-10-26 4:46 pm | N/A N/A | iRhythm Technologies Inc. | IRTC | Novo A/S 10% Owner | 2,007,449 | $0 | 2,124,448 (Direct) | View |
| 2016-10-31 Conversion | 2016-11-02 4:54 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner | 924,970 | $0 | 2,031,562 (Direct) | View |
| 2016-10-31 Conversion | 2016-11-02 4:54 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner | 860,438 | $0 | 2,031,562 (Direct) | View |
| 2016-10-31 Conversion | 2016-11-02 4:54 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner | 924,970 | $0 | 2,031,562 (Direct) | View |
| 2016-10-31 Conversion | 2016-11-02 4:54 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Novo A/S 10% Owner | 860,438 | $0 | 2,031,562 (Direct) | View |
| 2017-01-31 Conversion | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 1,428,571 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Conversion | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 486,820 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Conversion | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 312,986 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Conversion | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 673,454 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Exercise | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 81,673 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Conversion | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 1,428,571 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Conversion | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 486,820 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Conversion | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 312,986 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Conversion | 2017-02-01 4:22 pm | N/A N/A | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 673,454 | $0 | 3,033,504 (Direct) | View |
| 2017-01-31 Exercise | 2017-02-01 4:22 pm | N/A 2018-11-04 | ANAPTYSBIO INC | ANAB | Novo A/S 10% Owner | 117,235 | $4.55 | 3,033,504 (Direct) | View |
| 2017-06-22 Sale | 2017-06-23 4:34 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Novo Holdings A/S 10% Owner | 1,200,000 | $25 | 1,201,969 (Direct) | View |
| 2018-09-28 Conversion | 2018-10-01 4:36 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Novo Holdings A/S 10% Owner | 1,092,008 | $0 | 2,181,843 (Direct) | View |
| 2018-09-28 Conversion | 2018-10-01 4:36 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Novo Holdings A/S 10% Owner | 7,000,000 | $0 | 2,181,843 (Direct) | View |
| 2018-09-28 Conversion | 2018-10-01 4:36 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Novo Holdings A/S 10% Owner | 14,237,288 | $0 | 2,181,843 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-14 4:31 pm | N/A N/A | Milestone Pharmaceuticals Inc. | MIST | Novo Holdings A/S 10% Owner | 1,377,048 | $0 | 2,674,470 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-14 4:31 pm | N/A N/A | Milestone Pharmaceuticals Inc. | MIST | Novo Holdings A/S 10% Owner | 964,089 | $0 | 2,674,470 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-14 4:31 pm | N/A N/A | Milestone Pharmaceuticals Inc. | MIST | Novo Holdings A/S 10% Owner | 1,377,048 | $0 | 2,674,470 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-14 4:31 pm | N/A N/A | Milestone Pharmaceuticals Inc. | MIST | Novo Holdings A/S 10% Owner | 964,089 | $0 | 2,674,470 (Direct) | View |
| 2019-06-28 Conversion | 2019-07-01 4:31 pm | N/A N/A | Morphic Holding Inc. | MORF | Novo Holdings A/S 10% Owner | 1,978,779 | $0 | 2,645,446 (Direct) | View |
| 2019-06-28 Conversion | 2019-07-01 4:31 pm | N/A N/A | Morphic Holding Inc. | MORF | Novo Holdings A/S 10% Owner | 1,978,779 | $0 | 2,645,446 (Direct) | View |
| 2019-07-22 Conversion | 2019-07-23 4:32 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | Novo Holdings A/S 10% Owner | 1,870,147 | $0 | 2,445,147 (Direct) | View |
| 2019-07-22 Conversion | 2019-07-23 4:32 pm | N/A N/A | Mirum Pharmaceuticals Inc. | MIRM | Novo Holdings A/S 10% Owner | 1,870,147 | $0 | 2,445,147 (Direct) | View |
| 2019-11-12 Conversion | 2019-11-14 2:16 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Novo Holdings A/S 10% Owner | 2,373,152 | $0 | 3,409,021 (Direct) | View |
| 2019-11-12 Conversion | 2019-11-14 2:16 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Novo Holdings A/S 10% Owner | 535,869 | $0 | 3,409,021 (Direct) | View |
| 2019-11-12 Conversion | 2019-11-14 2:16 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Novo Holdings A/S 10% Owner | 12,000,000 | $0 | 3,409,021 (Direct) | View |
| 2019-11-12 Conversion | 2019-11-14 2:16 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Novo Holdings A/S 10% Owner | 2,709,659 | $0 | 3,409,021 (Direct) | View |